Regulation, clinical and biological significance of cathepsin D in breast cancer

Rev Esp Fisiol. 1990 Mar;46(1):39-41.

Abstract

The lysosomal protease, pro-cathepsin D, is overexpressed and secreted by human breast cancers. In estrogen-responsive breast cancer cell lines, estrogens and growth factors stimulate cathepsin D expression through distinct mechanisms. Clinical studies indicate that high cathepsin D concentration in primary breast cancers is correlated with an increased risk of metastasis and particularly useful to orientate node-negative tumors towards an adjuvant therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Cathepsin D / biosynthesis
  • Cathepsin D / physiology*
  • Enzyme Induction / drug effects
  • Estrogens* / pharmacology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Neoplasm Metastasis*
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / physiology*
  • Neoplasms, Hormone-Dependent / enzymology*
  • Neoplasms, Hormone-Dependent / metabolism
  • Neoplasms, Hormone-Dependent / pathology
  • Prognosis
  • Tumor Cells, Cultured / enzymology

Substances

  • Estrogens
  • Neoplasm Proteins
  • Cathepsin D